Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% shed 6.21% to $92.33 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% falling 1.15% to 14,340.26 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% falling 0.96% to 35,028.65. This was the stock's sixth consecutive day of losses. Novavax Inc. closed $239.35 short of its 52-week high ($331.68), which the company achieved on February 9th.
The stock underperformed when compared to some of its competitors Wednesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% fell 3.36% to $21.29, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% fell 1.07% to $1.85, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% fell 0.03% to $32.24. Trading volume (6.0 M) eclipsed its 50-day average volume of 5.7 M.